Project Grant HT94252410585
Award Date
9/15/24
Completion Date
9/14/28
Dollars Obligated
$3.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This federal Project Grant award for $773,399.00, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research at Case Western Reserve University to investigate neuromodulation for improving bladder function in a large animal model of spinal cord injury (SCI). The award, which runs from September 30, 2024 to September 29, 2027, will enable the university's researchers to explore innovative approaches to...
The Department of Defense's Defense Health Agency awarded a $9,870,517 Project Grant to Case Western Reserve University to conduct a pilot randomized controlled trial of the ISENS system for sensorimotor restoration after limb loss. The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund this research initiative from July 1, 2025 through June 30, 2029. As a leading private research university, Case Western Reserve University will leverage its...
This three-year, $1,305,395 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program will fund research into trunk stability and seated reaching after spinal cord injury. The grantee, Case Western Reserve University, will investigate medical solutions for individuals with spinal cord injuries, with a subaward to the Cleveland VA Medical Research & Education Foundation to support the research efforts. The grant aims to transform...
This Project Grant award from the Defense Health Agency (DHA), under the Military Medical Research and Development program (CFDA 12.420), provides $872,237 to Case Western Reserve University (CWRU) to conduct pulmonary rehabilitation research for advanced lung cancer survivors. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions. This 3-year award, effective May 1, 2025 through April 30, 2028,...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
The Department of the Army Medical Command awarded Case Western Reserve University a $1,288,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to therapeutically target superclusters at genes driving childhood sarcoma from September 2021 through September 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
The U.S. Department of Defense (DoD) awarded a $497,747 project grant to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel, central nervous system-penetrant synthetic oleanane triterpenoid for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and aggressive form of pediatric brain...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...